David is an Associate Consultant at Recon Strategy. His interests include understanding how market pressures affect the development of novel drugs and technologies, and how healthcare innovation can change patient care. Before joining Recon, David worked in laboratories that developed new cancer drugs and diagnostic technologies, and in a group that developed innovative health systems solutions.
David graduated from Dartmouth College with a BA in Biology modified with Chemistry and a Minor in Human Centered Design.
